ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• EDC For Mid-Study Changes In Medical Device Clinical Trials

  In this case study, discover how a company was pointed to an electronic data capture (EDC) system that was quick to adapt and easy to scale as the study changed.

• The Future Of Remote Patient Monitoring In Decentralized Clinical Trials

  Remote Patient Monitoring (RPM) is not just an innovation—it's a catalyst redefining how clinical research is conducted in the digital age.

• AI, Virtual Participants, and the Evolving FDA Regulatory Landscape

  Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.

• Minimizing Hurdles For Patients During The eConsent Process

  Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.

• Mitigating Study Risk With Performance Analytics

  Performance metrics for supporting risk-based management can be great, however, this author tells readers why collecting and analyzing data after a study has begun may not be the best approach.

• Shaping The Future Of eCOA User Acceptance Testing

  Proactive planning by sponsors and early User Acceptance Testing (UAT) involvement in the eCOA design process can substantially improve study quality, efficiency, and consistency.

• Consolidating Access Into A Single Platform: A Site CEO's Perspective

  By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

• Empowering Clinical Trial Sponsors With Analytics

  Explore data challenges faced by sponsors, the underlying problems driving those challenges, and flexible processes and solutions designed to help overcome them.

• 6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies

  Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.

• Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch

  The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.